Novel Sublingual Low-Dose Zolpidem Tablet Reduces Latency to Sleep Onset following Spontaneous Middle-of-the-Night Awakening in Insomnia in a Randomized, Double-Blind, Placebo-Controlled, Outpatient Study | Zendy

Thomas Roth | Zendy; Andrew D. Krystal | Zendy; Frank Steinberg | Zendy; Nikhilesh Singh | Zendy; Margaret Moline | Zendy

Open Access

Novel Sublingual Low-Dose Zolpidem Tablet Reduces Latency to Sleep Onset following Spontaneous Middle-of-the-Night Awakening in Insomnia in a Randomized, Double-Blind, Placebo-Controlled, Outpatient Study

Author(s) -

Thomas Roth,

Andrew D. Krystal,

Frank Steinberg,

Nikhilesh Singh,

Margaret Moline

Publication year - 2013

Publication title -

sleep

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.222

H-Index - 207

eISSN - 1550-9109

pISSN - 0161-8105

DOI - 10.5665/sleep.2370

Subject(s) - placebo , sleep onset , adverse effect , zolpidem , sleep onset latency , discontinuation , medicine , insomnia , anesthesia , primary insomnia , randomized controlled trial , psychology , sleep disorder , psychiatry , alternative medicine , pathology

To evaluate efficacy and safety of 3.5-mg zolpidem tartrate sublingual tablets (ZST) on latency to sleep onset after middle-of-the-night (MOTN) awakenings in patients with insomnia characterized by difficulty returning to sleep after MOTN awakenings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research